Inventor · disambiguated record
David Festus Charles Moffat
Also filed as: MOFFAT DAVID F C · MOFFAT DAVID FESTUS · MOFFAT DAVID FESTUS C · MOFFAT DAVID FESTUS CHARLES
32 granted patents·19 pending applications·1,954 citations·filing 1996–2018
98Inventor score
Files withCHROMA THERAPEUTICS LTD16CELLTECH THERAPEUTICS LTD9CELLTECH R&D LTD7DONALD ALASTAIR DAVID GRAHAM4GLAXOSMITHKLINE IP DEV LTD3
Top patents by PatentIndex Score
51 records- 0198US6579983B15-cyano-2-aminopyrimidine derivativesCELLTECH R&D LTD·Filed 2000·Granted Jun 17, 2003·228 cites·5 claims
- 0298US6235746B1Substituted 2-anilinopyrimidines useful as protein kinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1999·Granted May 22, 2001·290 cites·12 claims
- 0398US6093716ASubstituted 2-pyrimidineamines and processes for their preparationCELLTECH THERAPEUTICS LTD·Filed 1997·Granted Jul 25, 2000·267 cites·7 claims
- 0498US5958935ASubstituted 2-anilinopyrimidines useful as protein kinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1996·Granted Sep 28, 1999·361 cites·23 claims
- 0597US6337335B1Substituted 2-anilinopyrimidines useful as protein kinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1999·Granted Jan 8, 2002·105 cites·20 claims
- 0694US8686032B2Enzyme inhibitorsDAVIDSON ALAN HORNSBY·Filed 2010·Granted Apr 1, 2014·45 cites·2 claims
- 0794US6600037B14,5-disubstituted-2-aminopyrimidinesCELLTECH R&D LTD·Filed 2000·Granted Jul 29, 2003·56 cites·2 claims
- 0894US6048866ASubstituted 2-anilinopryimidines useful as protein kinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1998·Granted Apr 11, 2000·113 cites·10 claims
- 0993US7932246B2Histone deacetylase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2006·Granted Apr 26, 2011·61 cites·6 claims
- 1092US6599908B1Fused polycyclic 2-aminopyrimidine derivativesCELLTECH R&D LTD·Filed 2000·Granted Jul 29, 2003·47 cites·11 claims
- 1192US6114333A2-Pyrimidineamine derivatives and processes for their preparationCELLTECH THERAPEUTICS LTD·Filed 1997·Granted Sep 5, 2000·103 cites·6 claims
- 1289US7939666B2Enzyme inhibitorsCHROMA THERAPEUTICS LTD·Filed 2006·Granted May 10, 2011·15 cites·22 claims
- 1387US8217050B2Adenine derivative as inhibitors of HSP90 for the treatment of cancerMOFFAT DAVID FESTUS CHARLES·Filed 2007·Granted Jul 10, 2012·15 cites·14 claims
- 1487US8148531B2Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activityDAVIDSON ALAN HORNSBY·Filed 2006·Granted Apr 3, 2012·11 cites·21 claims
- 1587US7973181B2Hydroxamic acid derivatives as inhibitors of HDAC enzymatic activityCHROMA THERAPEUTICS LTD·Filed 2006·Granted Jul 5, 2011·12 cites·21 claims
- 1686US6057329AFused polycyclic 2-aminopyrimidine derivativesCELLTECH THERAPEUTICS LTD·Filed 1997·Granted May 2, 2000·63 cites·15 claims
- 1784US8003695B2IKK-beta serine-threonine protein kinase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2007·Granted Aug 23, 2011·9 cites·11 claims
- 1884US5922741A5-aminopyrazoles useful as tyrosine kinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1997·Granted Jul 13, 1999·60 cites·16 claims
- 1983US6552029B12-pyrimidineamine derivatives and processes for their preparationCELLTECH R&D LTD·Filed 1999·Granted Apr 22, 2003·58 cites·13 claims
- 2079US9388136B2Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereofCHROMA THERAPEUTICS LTD·Filed 2013·Granted Jul 12, 2016·3 cites·3 claims
- 2177US9133104B2Enzyme inhibitorsCHROMA THERAPEUTICS LTD·Filed 2014·Granted Sep 15, 2015·3 cites·40 claims
- 2277US8778953B2Inhibitors of P38 map kinaseMOFFAT DAVID FESTUS CHARLES·Filed 2009·Granted Jul 15, 2014·4 cites·17 claims
- 2373US9896417B2Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereofCHROMA THERAPEUTICS LTD·Filed 2016·Granted Feb 20, 2018·1 cites·12 claims
- 2472US9273003B2Methods of treating lymphoma and rheumatoid arthritis with cyclopentyl (2S)-cyclohexyl[({6-[3-(hydroxyamino)-3-oxopropyl]pyridin-3-yl}methyl)amino]acetateGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Mar 1, 2016·1 cites·10 claims
- 2566US6133257AFused polycyclic 2-aminopyrimidine derivativesCELLTECH THERAPEUTICS LTD·Filed 1998·Granted Oct 17, 2000·23 cites·9 claims
- 2662US2010317865A1Enzyme and receptor modulationC O CHROMA THERAPEUTICS LTD·Filed 2009·Application pending·0 cites
- 2758US2004235876A14,5-Disubstituted-2-aminopyrimidinesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 2856US9636409B2Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine estersGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted May 2, 2017·0 cites·4 claims
- 2956US2005171134A14,5-Disubstituted-2-aminopyrimidinesCELLTECH R&D LTD·Filed 2005·Application pending·0 cites
- 3055US10370332B2Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereofMACROPHAGE PHARMA LTD·Filed 2018·Granted Aug 6, 2019·0 cites·8 claims
- 3155US2014088159A1Enzyme and receptor modulationDRUMMOND ALAN HASTINGS·Filed 2013·Application pending·0 cites
- 3255US2003212269A14.5-disubstituted-2-aminopyrimidinesFiled 2003·Application pending·0 cites
- 3352US9725407B2HDAC inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Aug 8, 2017·0 cites·17 claims
- 3452US2011046210A1Substituted thiopenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2009·Application pending·0 cites
- 3552US2011190306A1Inhibitors of PLKCHROMA THERAPEUTICS LTD·Filed 2009·Application pending·0 cites
- 3651US2002147339A15-cyano-2-aminopyrimidine derivativesFiled 2002·Application pending·0 cites
- 3749US9604940B22-aminopyrazine derivatives as CSF-1R kinase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2013·Granted Mar 28, 2017·0 cites·17 claims
- 3849US2010004250A1Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancerCHROMA THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 3947US7012076B2Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinasesCELLTECH R&D LTD·Filed 2001·Granted Mar 14, 2006·0 cites·4 claims
- 4046US2014155439A1Enzyme inhibitorsDONALD ALASTAIR DAVID GRAHAM·Filed 2014·Application pending·0 cites
- 4146US2011039920A1Inhibitors of ikk-beta serine-theronine protein kinaseCHROMA THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 4246US2010216802A1Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancerCHROMA THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 4346US2010267774A1P38 map kinase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 4445US2017157118A12-aminopyrazine derivatives as csf-1 r kinase inhibitorsCHROMA THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 4545US2013303576A1Enzyme inhibitorsDONALD ALASTAIR DAVID GRAHAM·Filed 2013·Application pending·0 cites
- 4641US11382902B2Treatment of cancer by stimulation of IL-12 productionMACROPHAGE PHARMA LTD·Filed 2018·Granted Jul 12, 2022·0 cites·24 claims
- 4739US2016193200A1Benzamide derivatives and their use as hsp90 inhibtorsCHROMA THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 4838US2014010762A1Imaging agentsDRUMMOND MARGARET STRUTHERS·Filed 2011·Application pending·0 cites
- 4938US2002115692A1Tryptophan derivativesFiled 2001·Application pending·0 cites
- 5037US9321718B2Benzamide derivatives and their use as HSP90 inhibtorsDONALD ALASTAIR DAVID GRAHAM·Filed 2011·Granted Apr 26, 2016·0 cites·9 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Festus Charles Moffat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →